Lenox Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Lenox Wealth Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1K	Hold	75	–	–	﹤0.01%	730
2021 Q4	$1K	Hold	75	–	–	﹤0.01%	910
2021 Q3	$1K	Hold	75	–	–	﹤0.01%	693
2021 Q2	$1K	Buy	+75	New	+$1.28K	﹤0.01%	679

Other funds holding TAK

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Lenox Wealth Advisors's TAK Position: Q1 2022 in Review

Lenox Wealth Advisors held its Takeda Pharmaceutical (TAK) position steady in Q1 2022 at 75 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #730.

Lenox Wealth Advisors first reported a position in TAK in Q2 2021 and has held it in 4 quarters since. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

Lenox Wealth Advisors held 75 shares of Takeda Pharmaceutical worth $1K as of Q1 2022.
Lenox Wealth Advisors left its Takeda Pharmaceutical share count unchanged in Q1 2022.
Takeda Pharmaceutical made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #730 holding.
Lenox Wealth Advisors first reported a position in Takeda Pharmaceutical in Q2 2021 and has held it in 4 quarters since.
288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.